B

BridgeBio

Develops therapies for genetic diseases

Scientific Communications and Publications Manager/Senior Manager

Technical WritingPosted on Nov 12
Full-timeRemote in USA

About the Job

Requirements

  • A Master's degree or higher in a scientific discipline is required.
  • A minimum of 2 years of experience developing content for medical publications is required.
  • Excellent medical writing skills in English are required.
  • Ability to understand, interpret, and effectively communicate complex scientific data.
  • Ability to work efficiently independently and in cross-functional teams in fast-paced environments.
  • Ability to manage multiple priorities and meet deadlines.
  • Proficiency in commonly used word processing, graphic, and bibliographic software.
  • Ability to travel approximately 10% is required.
  • Must be able to work during Pacific Time Zone working hours.
  • Must be legally authorized to work in the United States.

Responsibilities

  • Contribute to content development for diverse deliverables within medical publications and scientific communications.
  • Contribute to publication and communication plans.
  • Support publication activities, including collecting author agreements and financial disclosures, overseeing the publication review process, and managing abstract and conference submissions.
  • Create and maintain accurate and complete records of publication activities in compliance with BridgeBio standard operating procedures and industry standards.
  • Manage tactical scientific communication activities to ensure timelines and deliverables are maintained.
  • Ensure all outputs and activities meet high standards of scientific integrity and comply with industry standards.
  • Perform other associated tasks as required.

Desired Qualifications

  • Experience developing content for medical publications in the biotech or pharmaceutical industry is preferred.

About the Company

BridgeBio

Develops therapies for genetic diseases

BridgeBio Pharma develops medicines for genetic diseases using a decentralized subsidiary model, where each subsidiary focuses on a specific disease while sharing central resources. It advances multiple drug programs at once by leveraging genome sequencing, molecular biology, and patient data to translate research into therapies that target underlying genetic causes. The company differentiates itself through its independent subsidiary structure with centralized support, combined with data-driven decision making and a culture of transparent, evidence-based testing. Its goal is to bring effective, disease-modifying therapies to patients faster by advancing a diverse pipeline from discovery to commercialization through partnerships and eventual approval.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Palo Alto, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at BridgeBio

See more jobs